PyInvesting

Market research

1345.HK China Pioneer Pharma Holdings Limited

HK HKD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
3B
P/E ratio
18.33
Analyst target
3.39
Dividend yield
4.9%
Beta
-0.16

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

China Pioneer Pharma Holdings Limited is currently in a long term uptrend where the price is trading 25.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.

China Pioneer Pharma Holdings Limited's total revenue sank by 10.5% to $622M since the same quarter in the previous year.

Its net income has increased by 415.4% to $31M since the same quarter in the previous year.

Finally, its free cash flow grew by 58.2% to $101M since the same quarter in the previous year.

Based on the above factors, China Pioneer Pharma Holdings Limited gets an overall score of 4/5.